Le Lézard
Classified in: Health
Subjects: NPT, SVY

New Hospital Safety Grades Find Significant Improvements in Patient Experience Reports and Health Care-Associated Infections


For the first time, Leapfrog ranks metro areas on patient safety performance

WASHINGTON, May 1, 2024 /PRNewswire/ -- The Leapfrog Group, an independent national nonprofit driving a movement for patient safety, today released its spring 2024 Hospital Safety Grades, assigning an "A," "B," "C," "D" or "F" to nearly 3,000 general hospitals on how well they prevent medical errors, accidents and infections. Nationally, patient experience?a set of measures using patient-reported perspectives on hospital care?indicates significant signs of improvement since the fall 2023 Safety Grades, and preventable health care-associated infections show a sustained drop after unprecedented rates during the height of the pandemic.

For the first time, The Leapfrog Group ranks metro areas on hospital patient safety performance.

In addition to assigning letter grades to individual hospitals, The Leapfrog Group also reports best patient safety performance by state and, for the first time, by metro area based on highest percentage of "A" hospitals. In spring 2024, Utah ranks number one among states for the second cycle in a row. The top three metro areas are Allentown (Pennsylvania), Winston-Salem (North Carolina) and New Orleans (Louisiana).

"Patient experience is very difficult to influence without delivering better care, so these findings are encouraging," said Leah Binder, president and CEO of The Leapfrog Group. "We were also pleased to see the decrease in preventable infections, which cause terrible suffering and sometimes death. When we look at these positive trends, we see lives saved?and that is gratifying."

Patient experience is measured through the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, which the Centers for Medicare and Medicaid Services (CMS) uses to publicly report patients' perspectives of hospital care.

Of the over 30 measures used to generate Hospital Safety Grades, The Leapfrog Group reports on five patient experience measures that have a direct impact on patient safety outcomes:

Since the start of the pandemic, patient experience has worsened. This spring has shown the first sign of improvement with all measures significantly improving since fall 2023, but the measures are still far from pre-pandemic levels.

Since Leapfrog reported Hospital Safety Grades in fall 2022, when HAI rates were at their highest peak since 2016, 92% of hospitals have improved performance on at least one of three dangerous preventable infections. Average HAI scores have declined dramatically:

"While today's results are promising, patient safety remains a crisis-level hazard in health care. Some hospitals are much better than others at protecting patients from harm, and that's why we make the Hospital Safety Grade available to the public and why we encourage all hospitals to focus more attention on safety," said Binder. According to a summary of peer-reviewed research published in BMJ, an estimated 250,000 people a year die of preventable errors and infections in hospitals, which makes patient safety problems the third leading cause of death in the U.S.

State and Metro Area Rankings

The top 10 states with the highest percentage of "A" hospitals are Utah, Virginia, New Jersey, Colorado, Rhode Island, Alaska, Pennsylvania, North Carolina, South Carolina and Maine.

Spring 2024 Leapfrog Hospital Safety Grade State Rankings

For metropolitan areas, Leapfrog used core-based statistical areas (CBSAs) used by the U.S. Census and determined by the Office of Management and Budget (OMB). The 25 metro areas with the highest percentage of "A" hospitals are:

Spring 2024 Leapfrog Hospital Safety Grades by Metro Ranking

Leapfrog rankings were limited to areas with populations of 500,000 or greater with at least 6 graded hospitals. To view all ranked metropolitan areas, view the interactive map.

About Leapfrog
Founded in 2000 by large employers and other purchasers, The Leapfrog Group is an independent national nonprofit organization driving a movement for giant leaps for patient safety. Among its initiatives, the Leapfrog Hospital Safety Grade was launched in 2012 and assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections. It is the only hospital ratings program based exclusively on hospital prevention of medical errors and harm to patients. It is fully transparent and free to the public, and grades are updated biannually in the fall and in the spring. To look up your hospital's Safety Grade, please visit HospitalSafetyGrade.org. For more from Leapfrog, follow us on Twitter, LinkedIn, Facebook and Instagram and sign up for our newsletter.

SOURCE The Leapfrog Group


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: